Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir

International Journal of Cancer

Volumn 135, Issue 1, 2014, Pages 248-249

  Söderberg Naucler, Cecilia ^a   Peredo, Inti ^a,b   Rahbar, Afsar ^a   Hansson, Fredrik ^c   Nordlund, Anders ^c   Stragliotto, Giuseppe ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Department of Neurology Karolinska University Hospital ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL AGENTS; BRAIN NEOPLASMS; CYTOMEGALOVIRUS; FEMALE; GANCICLOVIR; GLIOBLASTOMA; HUMANS; MALE;

EID: 84899450232     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28663     Document Type: Article

References (10)

1. Liu C-J, Hu Y-W,. Immortal time bias in retrospective analysis: is there a survival benefit in patients with Glioblastoma receiving prolonged treatment of Valganciclovir. Int J Cancer 2013. doi: 10.1002/ijc.28664.
2. Soderberg-Naucler C, Rahbar A, Stragliotto G,. Survival in patients with glioblastoma receiving valganciclovir. N Eng J Med 2013; 369: 985-6.
3. Stragliotto G, Rahbar A, Solberg NW, et al. Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study. Int J Cancer 2013; 133: 1204-13.
4. Ho AM, Dion PW, Ng CS, et al. Understanding immortal time bias in observational cohort studies. Anaesthesia 2013; 68: 126-30.
5. Suissa S,. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 2007; 16: 241-9.
6. Levesque LE, Hanley JA, Kezouh A, et al. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ 2010; 340: b5087.
7. Cobbs CS, Harkins L, Samanta M, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 2002; 62: 3347-50.
8. Bhattacharjee B, Renzette N, Kowalik TF,. Genetic analysis of cytomegalovirus in malignant gliomas. J Virol 2012; 86: 6815-24.
9. Ranganathan P, Clark PA, Kuo JS, et al. Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples. J Virol 2012; 86: 854-64.
10. Baryawno N, Rahbar A, Wolmer-Solberg N, et al. Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Investig 2011; 121: 4043-55.